These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38714648)

  • 1. Characterizing the mechanism of action for mRNA therapeutics for the treatment of propionic acidemia, methylmalonic acidemia, and phenylketonuria.
    Baek R; Coughlan K; Jiang L; Liang M; Ci L; Singh H; Zhang H; Kaushal N; Rajlic IL; Van L; Dimen R; Cavedon A; Yin L; Rice L; Frassetto A; Guey L; Finn P; Martini PGV
    Nat Commun; 2024 May; 15(1):3804. PubMed ID: 38714648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translational Pharmacokinetic/Pharmacodynamic Model for mRNA-3927, an Investigational Therapeutic for the Treatment of Propionic Acidemia.
    Attarwala H; Lumley M; Liang M; Ivaturi V; Senn J
    Nucleic Acid Ther; 2023 Apr; 33(2):141-147. PubMed ID: 36577040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical and anaplerotic applications of in vitro models of propionic acidemia and methylmalonic acidemia using patient-derived primary hepatocytes.
    Collado MS; Armstrong AJ; Olson M; Hoang SA; Day N; Summar M; Chapman KA; Reardon J; Figler RA; Wamhoff BR
    Mol Genet Metab; 2020 Jul; 130(3):183-196. PubMed ID: 32451238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy for organic acidemias: Lessons learned from methylmalonic and propionic acidemia.
    Chandler RJ; Venditti CP
    J Inherit Metab Dis; 2024 Jan; 47(1):63-79. PubMed ID: 37530705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel small molecule approach for the treatment of propionic and methylmalonic acidemias.
    Armstrong AJ; Collado MS; Henke BR; Olson MW; Hoang SA; Hamilton CA; Pourtaheri TD; Chapman KA; Summar MM; Johns BA; Wamhoff BR; Reardon JE; Figler RA
    Mol Genet Metab; 2021 May; 133(1):71-82. PubMed ID: 33741272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of long-term effectiveness of the use of carglumic acid in patients with propionic acidemia (PA) or methylmalonic acidemia (MMA): study protocol for a randomized controlled trial.
    Nashabat M; Obaid A; Al Mutairi F; Saleh M; Elamin M; Ahmed H; Ababneh F; Eyaid W; Alswaid A; Alohali L; Faqeih E; Aljeraisy M; Hussein MA; Alasmari A; Alfadhel M
    BMC Pediatr; 2019 Jun; 19(1):195. PubMed ID: 31196016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Early Cost-Utility Model of mRNA-Based Therapies for the Treatment of Methylmalonic and Propionic Acidemia in the United Kingdom.
    Bretos-Azcona PE; Wallace M; Jootun M; Jin G; Agirrezabal I; Szende A
    Clin Drug Investig; 2024 Jun; 44(6):399-412. PubMed ID: 38796677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver transplantation in propionic and methylmalonic acidemia: A single center study with literature review.
    Pillai NR; Stroup BM; Poliner A; Rossetti L; Rawls B; Shayota BJ; Soler-Alfonso C; Tunuguntala HP; Goss J; Craigen W; Scaglia F; Sutton VR; Himes RW; Burrage LC
    Mol Genet Metab; 2019 Dec; 128(4):431-443. PubMed ID: 31757659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylmalonic acidemia/propionic acidemia - the biochemical presentation and comparing the outcome between liver transplantation versus non-liver transplantation groups.
    Chu TH; Chien YH; Lin HY; Liao HC; Ho HJ; Lai CJ; Chiang CC; Lin NC; Yang CF; Hwu WL; Lee NC; Lin SP; Liu CS; Hu RH; Ho MC; Niu DM
    Orphanet J Rare Dis; 2019 Apr; 14(1):73. PubMed ID: 30940196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers for drug development in propionic and methylmalonic acidemias.
    Longo N; Sass JO; Jurecka A; Vockley J
    J Inherit Metab Dis; 2022 Mar; 45(2):132-143. PubMed ID: 35038174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of 2,2-Dimethylbutanoic Acid (HST5040), a Clinical Development Candidate for the Treatment of Propionic Acidemia and Methylmalonic Acidemia.
    Armstrong AJ; Henke BR; Collado MS; Taylor JM; Pourtaheri TD; Dillberger JE; Roper TD; Wamhoff BR; Olson MW; Figler RA; Hoang SA; Reardon JE; Johns BA
    J Med Chem; 2021 Apr; 64(8):5037-5048. PubMed ID: 33848153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved therapeutic efficacy in two mouse models of methylmalonic acidemia (MMA) using a second-generation mRNA therapy.
    Coughlan KA; Eybye M; Henderson N; DeAntonis CM; Frassetto A; Hanahoe E; Ketova T; Jacquinet E; Presnyak V; Jain R; Marshall J; Martini PGV
    Mol Genet Metab; 2024; 143(1-2):108560. PubMed ID: 39121792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propionic and methylmalonic acidemia: antisense therapeutics for intronic variations causing aberrantly spliced messenger RNA.
    Rincón A; Aguado C; Desviat LR; Sánchez-Alcudia R; Ugarte M; Pérez B
    Am J Hum Genet; 2007 Dec; 81(6):1262-70. PubMed ID: 17966092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective evaluation of the Dutch pre-newborn screening cohort for propionic acidemia and isolated methylmalonic acidemia: What to aim, expect, and evaluate from newborn screening?
    Haijes HA; Molema F; Langeveld M; Janssen MC; Bosch AM; van Spronsen F; Mulder MF; Verhoeven-Duif NM; Jans JJM; van der Ploeg AT; Wagenmakers MA; Rubio-Gozalbo ME; Brouwers MCGJ; de Vries MC; Langendonk JG; Williams M; van Hasselt PM
    J Inherit Metab Dis; 2020 May; 43(3):424-437. PubMed ID: 31828787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia.
    Baumgartner MR; Hörster F; Dionisi-Vici C; Haliloglu G; Karall D; Chapman KA; Huemer M; Hochuli M; Assoun M; Ballhausen D; Burlina A; Fowler B; Grünert SC; Grünewald S; Honzik T; Merinero B; Pérez-Cerdá C; Scholl-Bürgi S; Skovby F; Wijburg F; MacDonald A; Martinelli D; Sass JO; Valayannopoulos V; Chakrapani A
    Orphanet J Rare Dis; 2014 Sep; 9():130. PubMed ID: 25205257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effectiveness of carglumic acid in patients with propionic acidemia (PA) and methylmalonic acidemia (MMA): a randomized clinical trial.
    Alfadhel M; Nashabat M; Saleh M; Elamin M; Alfares A; Al Othaim A; Umair M; Ahmed H; Ababneh F; Al Mutairi F; Eyaid W; Alswaid A; Alohali L; Faqeih E; Almannai M; Aljeraisy M; Albdah B; Hussein MA; Rahbeeni Z; Alasmari A
    Orphanet J Rare Dis; 2021 Oct; 16(1):422. PubMed ID: 34635114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid organ transplantation in methylmalonic acidemia and propionic acidemia: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG).
    Sen K; Burrage LC; Chapman KA; Ginevic I; Mazariegos GV; Graham BH;
    Genet Med; 2023 Feb; 25(2):100337. PubMed ID: 36534118
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathophysiology of propionic and methylmalonic acidemias. Part 2: Treatment strategies.
    Haijes HA; van Hasselt PM; Jans JJM; Verhoeven-Duif NM
    J Inherit Metab Dis; 2019 Sep; 42(5):745-761. PubMed ID: 31119742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term efficacy and safety of mRNA therapy in two murine models of methylmalonic acidemia.
    An D; Frassetto A; Jacquinet E; Eybye M; Milano J; DeAntonis C; Nguyen V; Laureano R; Milton J; Sabnis S; Lukacs CM; Guey LT
    EBioMedicine; 2019 Jul; 45():519-528. PubMed ID: 31303505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a signs and symptoms outcome measure for caregivers of patients with methylmalonic acidemia and propionic acidemia (MMAPAQ).
    Sikirica V; Schwartz EJ; Vockley J; Stagni K; Bellenger MA; Banerjee G; Durgam N; Moshkovich O
    Mol Genet Metab; 2024; 143(1-2):108577. PubMed ID: 39303317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.